Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.humimm.2006.02.025 http://scihub22266oqcxt.onion/10.1016/j.humimm.2006.02.025 16698422!?!16698422 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=16698422&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Hum+Immunol 2006 ; 67 (1-2): 27-32 Nephropedia Template TP {{tp|p=16698422|t=2006. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection |pdf=|usr=}}{{16698422}} gab.com Text Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection JO: Hum Immunol http://www.kidney.de/pget.php?&tw=1&pmid=16698422 #FOAvip Interleukin-6 (IL-6) is an important cytokine in liver regeneration, and elevated levels of IL-6 have been demonstrated in patients with chronic liver diseases (CLD). Many biological effects of IL-6 depend on naturally occurring soluble IL-6 receptors. In the present study we measured the concentrations of IL-6 and its soluble receptors in the sera of patients with CLD related to hepatitis C virus (HCV) infection. We studied 77 patients with varying degrees of HCV-related CLD. Serum levels of IL-6 and its soluble receptors (sIL-6R, sgp130) were measured by enzyme-linked immunosorbent assay. Serum IL-6 and sIL-6R were elevated in patients with CLD compared with healthy subjects. Serum levels of sgp130 did not differ between patients with chronic hepatitis and healthy subjects. However, in patients with liver cirrhosis, sgp130 was significantly elevated and was positively correlated with total bilirubin and negatively correlated with cholinesterase and prothrombin time. Our study demonstrated that in patients with HCV-related CLD, serum IL-6 and its soluble receptor levels are correlated with both liver function impairment and the degree of liver fibrosis. These observations suggest that the balance of IL-6 and its soluble receptors may correspond to the state of liver damage in patients with CLD. Twit Text FOAVip Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection ????Hum Immunol http://www.kidney.de/pget.php?&tw=1&pmid=16698422 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=16698422 #FOAvip English Wikipedia <ref>{{Cite pmid|16698422}}</ref> Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection #MMPMID16698422 Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H Hum Immunol 2006[Jan]; 67 (1-2): 27-32 PMID16698422show ga Interleukin-6 (IL-6) is an important cytokine in liver regeneration, and elevated levels of IL-6 have been demonstrated in patients with chronic liver diseases (CLD). Many biological effects of IL-6 depend on naturally occurring soluble IL-6 receptors. In the present study we measured the concentrations of IL-6 and its soluble receptors in the sera of patients with CLD related to hepatitis C virus (HCV) infection. We studied 77 patients with varying degrees of HCV-related CLD. Serum levels of IL-6 and its soluble receptors (sIL-6R, sgp130) were measured by enzyme-linked immunosorbent assay. Serum IL-6 and sIL-6R were elevated in patients with CLD compared with healthy subjects. Serum levels of sgp130 did not differ between patients with chronic hepatitis and healthy subjects. However, in patients with liver cirrhosis, sgp130 was significantly elevated and was positively correlated with total bilirubin and negatively correlated with cholinesterase and prothrombin time. Our study demonstrated that in patients with HCV-related CLD, serum IL-6 and its soluble receptor levels are correlated with both liver function impairment and the degree of liver fibrosis. These observations suggest that the balance of IL-6 and its soluble receptors may correspond to the state of liver damage in patients with CLD. |*Liver Regeneration[MESH] |Aged[MESH] |Chronic Disease[MESH] |Cytokine Receptor gp130/blood[MESH] |Female[MESH] |Hepacivirus/*immunology[MESH] |Hepatitis C/blood/*immunology[MESH] |Humans[MESH] |Interleukin-6/*blood[MESH] |Liver Diseases/immunology[MESH] |Male[MESH] |Middle Aged[MESH] |Prognosis[MESH]Serum levels of interleukin-6 and its soluble receptors in patients wi(epmc).pdf DeepDyve Pubget Overpricing